◀ Back to IGF2

IGF2 — PTPRF

Text-mined interactions from Literome

Helle et al., Eur J Cancer 2005 (Breast Neoplasms) : Effects of tamoxifen and octreotide LAR on the IGF-system compared with tamoxifen monotherapy
Potter et al., Pituitary 2008 (Acromegaly...) : Octreotide LAR reduced GH, IGF-1 and insulin resistance index but did not alter levels of CRP and NT-pro BNP
Attia et al., Clin Adv Hematol Oncol 2008 (Carcinoma, Hepatocellular...) : To correlate the effect of octreotide long acting release (LAR) on insulin-like growth factor-I (IGF-I) and -II ( IGF-II ) with response and survival in patients with unresectable and metastatic hepatocellular carcinoma